The Binding Site: Freelite Overview
Siteman Cancer Center: Autologous stem cell transplant at Siteman Cancer Center
IMF - International Myeloma Foundation: Patient Handbook 2022
PE: CDC Guidelines: How to prevent infections (Sepsis) while getting chemotherapy?
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
National Cancer Institute: Clinical Trials Information for Patients and Caregivers
Dana-Farber's 2022 Multiple Myeloma Patient Symposium - Update on Multiple Myeloma Treatment
How to Prevent Neutropenic Sepsis on Treatment? Know Your ANC (Absolute Neutrophil Count)
You are central to the care team: Be Empowered - IMF Patient & Family Webinar - May 14, 2022
Multiple Myeloma Research Foundation - MMRF - Minimal Residual Disease (MRD)
Multiple Myeloma Research Foundation - MMRF - Multiple Myeloma Precursor Conditions
Multiple Myeloma Research Foundation - MMRF's The Right Track Program | High Impact Topic (HIT)
Patient Symposium - MCRT Webcast Myeloma Crowd Round Table, 10/16/2021 - St. Louis, Missouri
Siteman Cancer Center: Learn about cancer clinical trials and the benefits they offer patients
Multiple Myeloma Research Foundation - MMRF - Immunotherapy
NCCN Animation for Patients: What is Multiple Myeloma?
What is the best diet for myeloma patients to build a strong immune system? IMF
NCCN Patient Webinar: Multiple Myeloma
Multiple Myeloma Research Foundation - MMRF - Learn Your Labs | High Impact Topic (HIT)